Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[The impact of the COVID-19 pandemic on the Italian and foreign population in the various phases: the results of an interregional multicentre project].
Profili F, Stasi C, Silvestri C, Ferroni E, Zorzi M, Ventura M, Petrelli A, Spadea T, Rusciani R, Bartolini L, Caranci N, Cacciani L, Calandrini E, Maifredi G, Leoni O, Voller F; Gruppo di lavoro INMP Covid19 e immigrati. Profili F, et al. Among authors: maifredi g. Epidemiol Prev. 2022 Jul-Aug;46(4):71-79. doi: 10.19191/EP22.4S1.058. Epidemiol Prev. 2022. PMID: 35862562 Free article. Italian.
Phase II study of interferon alpha-2a and dacarbazine in advanced melanoma.
Bajetta E, Negretti E, Giannotti B, Brogelli L, Brunetti I, Sertoli MR, Bernengo MG, Sofra MC, Maifredi G, Zumiani G, et al. Bajetta E, et al. Among authors: maifredi g. Am J Clin Oncol. 1990 Oct;13(5):405-9. doi: 10.1097/00000421-199010000-00008. Am J Clin Oncol. 1990. PMID: 2220660 Clinical Trial.
[Hospital assistance for COVID-19: a comparison between non-Italian and Italian resident population in five Italian Regions since the beginning of the pandemic until June 2021].
Cacciani L, Calandrini E, Cascini S, Spadea T, Rusciani R, Ercolanoni M, Maifredi G, Ferroni E, Bartolini L, Caranci N, Silvestri C, Profili F, Cernigliaro A, Petrelli A, Di Napoli A, Davoli M, Agabiti N; Gruppo di lavoro INMP Covid19 e immigrati. Cacciani L, et al. Among authors: maifredi g. Epidemiol Prev. 2022 Jul-Aug;46(4):49-58. doi: 10.19191/EP22.4S1.056. Epidemiol Prev. 2022. PMID: 35862560 Free article. Italian.
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A, Fazzo L, Benedetti M, Bruno C, Vecchi S, Pasetto R, Minichilli F, De Santis M, Nannavecchia AM, Di Fonzo D, Contiero P, Ricci P, Bisceglia L, Manno V, Minelli G, Santoro M, Gorini F, Ancona C, Scondotto S, Soggiu ME, Scaini F, Beccaloni E, Marsili D, Villa MF, Maifredi G, Magoni M, Iavarone I; Gruppo di lavoro SENTIERI 2019-2022. Zona A, et al. Among authors: maifredi g. Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli A, Cuccaro F, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino M, Carrozzi G, Stracci F, Michiara M, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Rizzello RV, Mian M, Cascone G, Boschetti L, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Dal Maso L; AIRTUM Working Group. Toffolutti F, et al. Front Oncol. 2023 Jun 6;13:1168325. doi: 10.3389/fonc.2023.1168325. eCollection 2023. Front Oncol. 2023. PMID: 37346072 Free PMC article.
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
Dal Maso L, Toffolutti F, De Paoli A, Giudici F, Francisci S, Bucchi L, Zorzi M, Fusco M, Caldarella A, Rossi S, De Angelis R, Botta L, Ravaioli A, Casella C, Musolino A, Vitale MF, Mangone L, Fanetti AC, Carpin E, Burgio Lo Monaco MG, Migliore E, Gambino ML, Ferrante M, Stracci F, Gasparotti C, Carrozzi G, Cavallo R, Mazzucco W, Ballotari P, Ferretti S, Sampietro G, Rizzello RV, Boschetti L, Cascone G, Mian M, Pesce MT, Piras D, Galasso R, Bella F, Seghini P, Pinna P, Crocetti E, Serraino D, Guzzinati S; AIRTUM Working Group. Dal Maso L, et al. Int J Cancer. 2024 Jul 15;155(2):270-281. doi: 10.1002/ijc.34923. Epub 2024 Mar 23. Int J Cancer. 2024. PMID: 38520231
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.
De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. De Angelis R, et al. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30. Lancet Oncol. 2024. PMID: 38307102
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group. Sant M, et al. Lancet Oncol. 2024 May 1:S1470-2045(24)00141-4. doi: 10.1016/S1470-2045(24)00141-4. Online ahead of print. Lancet Oncol. 2024. PMID: 38703784
23 results